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Abstract
Background: The options for treating the fatal disease human African trypanosomiasis are limited to a few drugs that are
toxic or facing increasing resistance. New drugs that kill the causative agents, subspecies of Trypanosoma brucei, are
therefore urgently needed. Little is known about the cellular mechanisms that lead to death of the pathogenic bloodstream
stage.
Methodology/Principal Findings: We therefore conducted the first side by side comparison of the cellular effects of
multiple death inducers that target different systems in bloodstream form parasites, including six drugs (pentamidine,
prostaglandin D2, quercetin, etoposide, camptothecin, and a tetrahydroquinoline) and six RNAi knockdowns that target
distinct cellular functions. All compounds tested were static at low concentrations and killed at high concentrations. Dead
parasites were rapidly quantified by forward and side scatter during flow cytometry, as confirmed by ethidium homodimer
and esterase staining, making these assays convenient for quantitating parasite death. The various treatments yielded
different combinations of defects in mitochondrial potential, reactive oxygen species, cell cycle, and genome segregation.
No evidence was seen for phosphatidylserine exposure, a marker of apoptosis. Reduction in ATP levels lagged behind
decreases in live cell number. Even when the impact on growth was similar at 24 hours, drug-treated cells showed dramatic
differences in their ability to further proliferate, demonstrating differences in the reversibility of effects induced by the
diverse compounds.
Conclusions/Significance: Parasites showed different phenotypes depending on the treatment, but none of them were
clear predictors of whether apparently live cells could go on to proliferate after drugs were removed. We therefore suggest
that clonal proliferation assays may be a useful step in selecting anti-trypanosomal compounds for further development.
Elucidating the genetic or biochemical events initiated by the compounds with the most profound effects on subsequent
proliferation may identify new means to activate death pathways.
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Introduction
In the absence of a vaccine, control of the lethal disease human
African trypanosomiasis (also known as African sleeping sickness)
relies on case treatment and elimination of the tsetse fly vector
which carries the infecting trypanosomes. However, treatment is
hampered by challenges of drug toxicity, resistance, and regimens
unrealistic for resource-limited settings. Once the trypanosomes
cross the blood brain barrier, the drug melarsoprol is typically used
in endemic areas and this treatment alone has approximately 5%
mortality [1]. The animal pathogen Trypanosoma brucei brucei serves
as the common model for the African trypanosomes with only a
few differences at the genomic level from the human pathogen
Trypanosoma brucei rhodesiense; it is slightly less related to the other
human pathogen, Trypanosoma brucei gambiense. All but one of the
currently approved drugs for African trypanosomiasis were
discovered via screening for activity against whole cells and their
cellular targets remain unknown. For medium and high through-
put screening of the pathogenic bloodstream form (BF) of T. brucei,
recent studies have used ATP levels in the culture as a barometer
of parasite growth inhibition [2]. Another assay that has been used
relies on the reduction of Alamar blue (resazurin) to a red
fluorescent compound in live cells [3,4]. Neither of these assays
specifically assesses parasite death.
Over the past several years, it has become clear that there are
many pathways towards death in metazoan cells. Among these are
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independent cell death, oncosis, and autophagy. Potential
orthologues of some of the proteins participating in these pathways
are encoded in the genomes of African trypanosomes. Examples
include the lysosomal cathepsins [5] and endonuclease G [6],
which play prominently in caspase-independent cell death. Genes
encoding poly(ADP-ribose) polymerase [7] and calpains [8], which
play a role in metazoan oncosis, are also present. The set of genes
involved in autophagy in T. brucei is somewhat reduced [9]; these
genes may be involved in life cycle transitions in the parasite [10].
Whether any of these potential mediators play a broad role in the
death of BF remains to be seen.
Conversely, genes encoding caspases, which are by definition
involved in apoptosis, are absent from the trypanosome genomes.
Three metacaspases, which are related to caspases, are expressed
in BF, but triple deletion mutants remained sensitive to PGD2-
induced cell death [11]. Also absent are genes encoding molecules
that participate in the extrinsic pathway of apoptosis, such as the
death receptors (e.g., Fas receptors) or their downstream
mediators, DED domain proteins. The intrinsic pathway of
apoptosis involves permeabilization of the outer membrane of
the mitochondrion and leakage of components of the intermem-
brane space into the cytosol. Cytochrome c plays a key role in this
pathway, but, unlike procyclic forms, BF lack this protein [12].
In contrast to tens of papers describing programmed cell death
(PCD) like phenomena in drug-induced killing of the related
parasite Leishmania, relatively few studies have explored the
pathways of cell death in T. brucei. The large majority of these
focused on the procyclic stage which differs extensively from the
BF stage as to surface molecules and metabolism. Indeed, very few
studies have been published concerning pathways of cell death in
BF. The phytoflavonol quercetin was reported to kill BF in a
mechanism that included phosphatidylserine exposure, a feature
commonly seen in mammalian cells undergoing apoptosis [13].
Also of note is a study of prostaglandin D2 (PGD2) that showed
changes in mitochondrial potential, DNA degradation, and
phosphatidylserine exposure at the parasite surface [14] in a
death process that included oxidative stress [15]. Diamidines, such
as pentamidine, were shown to target mitochondrial functions,
although they may have additional cellular targets [16]. We were
curious as to whether there are distinct pathways of cell death in
BF that might be exploited to develop more effective assays for
identifying or characterizing potentially useful compounds. We
therefore tested a number of potential medium to high throughput
assays to see if any would be particularly useful in detecting BF
death induced by drugs or RNAi, and if these assays could
distinguish different phenotypes of cell death resulting from the
various treatments.
Materials and Methods
Drugs
PGD2 (Sigma) was resuspended in phosphate buffered saline
(PBS) to 5 mM. Pentamidine isethionate (Sigma) was resuspended
in water to 10 mM. Quercetin dihydrate was freshly dissolved in
dimethylsulfoxide to 100 mM for each experiment. Camptothecin
(Sigma), etoposide (Sigma) and tetrahydroquinoline compound 4G
(kindly provided by Dr. Fred Buckner) [17] were all dissolved in
dimethylsulfoxide to 5 mM, 100 mM and 20 mM stocks respec-
tively.
Strains and media
All work used the BF T. b. brucei single marker line, a derivative
of the 427 strain that expresses both T7 RNA polymerase and the
tetracycline (Tet) repressor, allowing for Tet-regulated expression
of transfected sequences [18]. The sole exception is the KREPA3
(systematic ID Tb927.8.620) conditional knockout line, which was
constructed in strain 427 [19]. BF, which divide about every eight
hours, were maintained at densities below 1.5610
6 cells/ml in
HMI-9 supplemented with 10% fetal calf serum and 2.5 mg/ml
G418. For assays of drug effects, G418 was eliminated from the
media. The KREPA3 conditional knockout [19] and PFT-bRNAi
(Tb927.7.460) [20] BF lines were gifts of Dr. Kenneth Stuart and
Dr. Fred Buckner respectively. The PEX19 (Tb09.211.3300)
RNAi BF line was previously described [21]. Cell counts from BF
cultures were taken using a Beckman Coulter Counter. To ensure
reproducible assays, parasite density was carefully controlled prior
to drug treatment or induction of RNAi. Allowing parasites to
grow to higher densities in the few days before drug treatment led
to higher assay variation. Cultures were diluted to 2610
5 cells/ml
with fresh media. By 24 hours, the parasite density reached
121.4610
6 cells/ml. Cultures were again diluted to 2610
5 cells/
ml and 1 ml of diluted culture per well was placed into 24 well
untreated tissue culture plates. Drugs were then added at the
indicated concentration (in triplicate) and the parasites were
incubated for an additional 24 hours before analysis, except as
noted. Alternatively, expression from Tet-regulated constructs was
induced with 1–2 mg/ml Tet.
After preliminary studies to determine the approximate plating
efficiency of drug-treated cells, limiting dilution analysis as described by
Kimball (http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/
L/LimitingDilution.html) was conducted by plating three cell
concentrations (derived from two separate dilutions series) into 24
wells of a 96-well plate. The proportion of wells without growing cells
was determined at day 4 and plotted to allow extrapolation to the
plating efficiency. Untreated cells were plated at 0.3, 1 and 1.5 live cells
per well for comparison.
Plasmid construction and generation of RNAi lines
The plasmid pZJM-NOPP44/46 (Tb927.8.760) [22] was
transfected into the BF single-marker line as described [23] and
modified [24]. Stably integrated plasmids were selected with
Author Summary
The parasite Trypanosoma brucei causes human African
trypanosomiasis, which is fatal unless treated. Currently
used drugs are toxic, difficult to administer, and often are
no longer effective due to drug resistance. The search for
new drugs is long and expensive, and determining which
compounds are worth pursuing is a key challenge in that
process. In this study we sought to determine whether
different compounds elicited different responses in the
mammalian-infective stage of the parasite. We also
examined whether genetic knockdown of parasite mole-
cules led to similar responses. Our results show that,
depending on the treatment, the replication of the
parasite genomes, proper division of the cell, and
mitochondrial function can be affected. Surprisingly, these
different responses were not able to predict which
compounds affected the long term proliferative potential
of T. brucei. We found that some of the compounds had
irreversible effects on the parasites within one day, so that
even cells that appeared healthy could not proliferate. We
suggest that determining which compounds set the
parasites on a one-way journey to death may provide a
means of identifying those that could lead to drugs with
high efficacy.
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both subunits of TOPIBS (Tb09.160.5070) and TOPIBL
(Tb927.4.1330) and the mitochondrial topoisomerase II, TOPIImt
(Tb09.160.4090) primers were designed against regions of the
genes that had been shown previously to be effective in leading to
depletion of the endogenous mRNA when expressed as dsRNA
[25,26]. The forward primers TOPIBS-S (CTCGAGTTATGT-
GATTTCAGTG), TOPIBL-S (GGTGGCTCATCTTCAGT-
TG), and TOPIImt-S(TAGGCTTTCAGGGTGAGATACGTC)
were used in conjunction with the reverse primers TOPIBS-AS
(AAGCTTGTAAACTTCTGGCAGGAC), TOPIBL-AS (AAT-
GGGGACGTTGTTCTCGTTG), and TOPIImt-AS(TTTACG-
CAAAATGTAGTCGAACGAG) to amplify segments of the
genes from genomic DNA isolated from the T. brucei strain
29.13. PCR fragments were directly ligated into Eam 1105I
digested p2T7
TABlue-PAC, a derivative of the plasmid p2T7
TABlue
where the hygromycin resistance gene had been replaced with the
puromycin resistance gene (B. Jensen unpublished). Parasites were
transfected as described above and transfectants with stably
integrated plasmids were selected with 1 mg/ml puromycin. BF
transfectants were assumed to be clonal since less than 1/3 of wells
yielded transfectants.
ATP assay
ATP was measured in a bioluminescence 96-well plate assay
following the manufacturer’s protocol (Roche). All conditions were
tested in triplicate. From each triplicate culture, three 25 ml
aliquots were flash frozen and stored at 270u until assay. The
luminescence obtained was compared with that seen in a dilution
series of ATP, as detected by a Fluroskan Ascent Fl luminometer
(Thermo Labsystems).
Flow cytometry
Prior to staining, 10
6 BF were pelleted by centrifugation for 10
minutesat 30006g and washed in PSG (phosphate buffered saline
with 10 mM glucose) unless otherwise indicated. Samples were
analyzed on a Beckman Coulter Epics XL-MCL and analyzed
using FlowJo software (Treestar software). Compensation of
spectral overlap was performed using single-stained control cells
within the FlowJo software. Compensation was manually correct-
ed as needed to ensure that single-stained cells did not fall below
the axis. All flow cytometry experiments were performed at least
twice for each condition unless otherwise noted.
Live/Dead assay. Parasites were resuspended in 0.5 ml
PSG. Calcein was added to 0.2 mM( 2ml of 1:80 dilution of 4 mM
stock, Invitrogen) and ethidium homodimer was added to 16 mM
(4 ml of 2 mM stock, Invitrogen). Samples were incubated for 20
minutes at room temperature and analyzed immediately by flow
cytometry with a 530/40 filter (calcein) and 692/40 filter
(ethidium homodimer).
Mitochondrial membrane potential. Washed parasites
were resuspended in 1 ml PSG, and then mixed with 1 mlo f
250 mM rhodamine 123 (Invitrogen) in water. After 20 minutes at
room temperature cells were washed with 4 ml PSG, and
resuspended in 1 ml PSG for immediate analysis with
florescence detected through a 530/40 filter. The relative
mitochondrial potential (as compared to untreated cells) was
determined, after gating on live cells by forward and side scatter.
Phosphatidylserine exposure and protease activation.
Washed parasites were resuspended in 0.5 ml annexin binding
buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2,1 0m M
glucose. pH 7.4). Parasites were then stained with 4 ml Annexin-V
FITC (Invitrogen) and 2 mg/ml propidium iodide (PI, Sigma) for
20 minutes at room temperature. They were then analyzed by flow
cytometry with a 530/40 filter (annexin) and 610/20 filter (PI). For
analysis of protease activation, 10
6 treated cells were incubated
with 5 mM pan-caspase substrate FITC-conjugated Val-Ala-DL-
Asp(O-methyl)-fluoromethylketone (FITC-VAD-fmk) in 0.5 ml
PSG for 20 minutes at room temperature. Cells were then
washed twice with 4 ml PSG and analyzed by flow cytometry with
a 530/40 filter.
Reactive oxygen species (ROS). Washed parasites (2610
6)
were resuspended with 1 ml PSG and 5-(and-6)-chloromethyl-
29,79-dichlorodihydrofluorsceine diacetate acetyl ester (CM-
H2DCFDA) was added to 2 mM. After 10 minutes at 37u,
parasites were pelleted and washed with PSG and resuspended in
1 ml HMI-9. After a 30 minute recovery period at 37u, drugs were
added. Following drug exposure, cells were again centrifuged,
resuspended in 1 ml PSG, and immediately analyzed by flow
cytometry with a 530/40 filter.
Cell cycle analysis and DNA degradation. Both
microscopic and flow analyses were used to assess potential cell
cycle defects of the treated parasites. For flow analysis, 10
6 RNAse-
treated parasites were stained with PI as described [27]. The
Dean-Jett-Fox algorithm within FloJo was used to estimate
proportions of parasites in G1, S and G2/M phases of the cell
cycle. For microscopy, parasites were fixed in 2% formaldehyde,
washed in 1 ml PBS, and spotted onto multiwell poly-L lysine-
coated slides. After 20 min, the liquid was then aspirated and cells
were permeablized with 0.1% Triton X-100 in PBS for 5 minutes.
After two washes with PBS, samples were stained with 2 mg/ml
49,6-diamidino-2-phenylindole (DAPI) in PBS for one hour. Slides
were then washed twice with PBS, mounted in Prolong antifade
reagent (Molecular Probes), and visualized on a Nikon E600
microscope. At least 200 parasites were counted for each
condition.
Results
Our survey of T. brucei BF death employed six compounds and
six RNAi cell lines, as well as overgrown cultures. For simplicity we
refer to these compounds as drugs, although only one, pentam-
idine is in clinical use for treatment of human African
trypanosomiasis (it is used to treat early stage gambiense form
human African trypanosomiasis). Of the six drugs examined, three
have known mechanisms of action. Tetrahydroquinoline 4G
(THQ4G) is an inhibitor of protein farnesyltransferase (PFT) [17]
(Fred Buckner, personal communication), which farnesylates
specific proteins, facilitating their localization to membranes.
The BF drugs camptothecin and etoposide inhibit topoisomerases
I and II respectively and camptothecin was previously shown to be
toxic to BF trypanosomes [28,29]. Quercetin and the biological
mediator PGD2, whose targets are not yet known, were used
because of their possible implication in PCD in T. brucei [13,14].
The mode of action of pentamidine is unknown, although it does
have mitochondrial targets [16]. Overgrown cultures (post-log
phase, densities above ,2.5610
6/ml), which go on to rapidly die
via an unknown mechanism, were also examined in some assays.
Drug treatments and viability
In order to observe processes that occur during BF death, we
determined drug concentrations that created a comparable
proportion of live and dead cells. We reasoned that such
populations would contain some cells in the process of dying. In
all drug studies, log-phase BF were used. Parasites were incubated
for 24 hours (a normal cell cycle is 6–8 hours) with concentrations
of drug spanning EC50 values obtained from the literature (see
Table 1). At each concentration total number of particles/ml was
Diverse Responses to Drugs in T. brucei
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distinguish between live parasites and dead parasites that are
relatively intact, a separate live/dead assay was performed to
determine the proportion of cell-sized particles that corresponded
to live parasites at each drug concentration. The resulting number
correlated highly with counts of motile parasites by microscopy
using a hemocytometer, but showed less inter-investigator
variability.
The live/dead assay was a calcein/ethidium homodimer double
stain. Calcein (a non-fluorescent, cell permeant compound) is
cleaved by an esterase in living cells to a green fluorescent
compound. Ethidium homodimer is cell-impermeant, and hence
its red fluorescence is detected only in dead cells. Although
ethidium and related compounds such as propidium iodide are
slowly taken up by trypanosomes via facilitated diffusion [30,31],
the background staining in control populations was low compared
to the intensity of staining of dead cells (Fig. 1). Most parasites
were either calcein-positive, ethidium-negative (alive) or calcein-
negative, ethidium-positive (dead). However, some double positive
cells were usually seen. We interpret these to be cells that had
recently died (were permeable to ethidium), but which had
residual esterase activity. In the example of pentamidine treated
cultures shown in Figure 1A, there were very few such cells.
However, with etoposide, up to half of the ethidium-stained cells
showed some, although typically lower, calcein fluorescence (data
not shown). Thus, using calcein alone could lead to an
overestimate of the proportion of live cells in cultures.
In analyzing the live/dead calcein/ethidium assay, we noted
that the live and dead populations of parasites could also be
determined by scatter (Figure 1A). By scatter, the parasites
grouped into two distinct populations: one with minimal forward
scatter, separated by a trough from one showing a broad
distribution of forward scatter. The distinction becomes clearer
when side scatter is included. Mapping the parasites from the
calcein/ethidium assay by scatter demonstrated that 98.8% of the
broadly distributed population showing higher forward scatter
were calcein-positive (live) parasites (Figure 1B), while less than 1%
of the population showing low forward scatter were calcein-
positive. This correlation was observed with every drug. Thus we
can determine the proportion of live parasites in a population with
either the calcein/ethidium assay or by scatter. Using these assays,
we were able to assess the number of live cells as compared to the
untreated control (Figure S1). Without any drug treatment, the
viability of untreated cells was typically greater than 90%. Shown
in Table 1 are the determined EC50 and EC75 for the six drugs
along with the published value for each (defined here as a 50% or
75% reduction in number of live cells after a 24 hour treatment).
The somewhat higher EC50s for THQ4G and pentamidine in the
current study likely result from the shorter incubation time used.
For each drug, lower concentrations (,EC70) reduced cell
numbers without increasing the proportion of dead cells at
24 hours (Figure S2). For all drugs, when the concentration of
drugs was increased, the proportion of live cells at 24 h dropped
precipitously. To assess loss of viability (as defined by the ability to
clonally proliferate), we turned to limiting dilution analysis.
Decreasing amounts of drug-treated cultures with known numbers
of live parasites were plated into the wells of microtiter plates. The
results showed that parasites treated with the different drugs at (or
near) the EC70 showed quite different plating efficiencies (see
Table 2). Camptothecin and quercetin had little impact on cell
viability, with most parasites that were alive after exposure able to
give rise to colonies. Etoposide and PGD2 had a moderate effect
on cell viability with approximately 25% of the cells able to
recover. THQ4G had a more profound effect on proliferative
potential, while pentamidine had a drastic effect. Indeed, we were
unable to observe any colonies arising following from pentamidine
treatment at EC75 implying a plating efficiency of less than 0.05%.
Strikingly, even a more mild treatment with pentamidine, which
resulted in only a 25% decrease in population growth after
24 hours, still had an extreme effect on the parasites, with only
0.4% of them able to recover and resume growth. Previous studies
showed that continued exposure to pentamidine over ten days
resulted in a much enhanced effect on T. gambiense growth and
viability as compared to the effect seen at 24 hours [32]. Our
results suggest that this enhancement includes a component
resulting from a commitment to a slow death that occurs within
the majority of cells in the first 24 hours of pentamidine exposure.
For the following experiments we aimed for a 75% reduction in
the number of ‘‘live’’ cells because that usually gave a good
representation of both live and dead cells for the assays. All drug
treatments were monitored by cell counting and forward/side
scatter to allow comparison of parasite populations showing
similar reductions in live cells, unless otherwise noted.
Effect of drugs on mitochondrial membrane potential,
ROS, and ATP levels
For a number of drugs that affect viability of trypanosomatids,
including pentamidine, the ultimate downstream target has been
proposed to be the mitochondrion [16]. As a measure of
mitochondrial health and function, we used the cell-permeant
Table 1. Drugs used in this study.
Compound Target or effect Published EC50 EC50
a EC75 Reference
camptothecin topoisomerase I 1.5 mM 0.55 mM 0.96 mM [28]
etoposide topoisomerase II n.a. 2.6 mM 5.58 mM n.a.
THQ4G b subunit of PFT 0.07 mM
b 0.25 mM 0.45 mM F. Buckner (personal
communication)
quercetin induces PCD 10 mM4 . 8 mM8 . 2 mM [13]
PGD2 induces PCD 3.7 mM3 . 8 mM7 . 4 mM [14]
pentamidine unknown 1.7 nM
c 4.4 nM 7.1 nM [44]
aAs determined by calcein/ethidium assay after 24 hour treatment (see Figure S1).
bThe cited study used a 48 hour exposure.
cThe cited study used a 72 hour exposure.
n.a., no previous reports were found in literature citing an EC50 for etoposide for BF.
doi:10.1371/journal.pntd.0000678.t001
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mitochondria of live cells as a consequence of their mitochondrial
membrane potential. Log-phase cells were incubated with each
drug for 24 hours and then stained with rhodamine 123. Parasites
were analyzed by flow cytometry, gating on live cells as
determined by scatter. Shown in Figure 2A is a representative
experiment comparing the mitochondrial potential of parasites
treated with the various compounds to that of untreated parasites.
To allow comparison of experiments done at different times, the
geometric mean of each sample was determined and then
normalized against an untreated control analyzed at the same
time. As seen in Figure 2A, the drugs PGD2, quercetin, and
pentamidine all induced a loss of mitochondrial membrane
potential compared to the untreated control. Camptothecin-
treated cells showed no significant difference in potential, while
etoposide-treated and THQ4G-treated cells showed slight increas-
es in rhodamine 123 fluorescence. These small increases seem to
be the consequence of an increase in cell size as seen by scatter,
since when after gating for cells of normal size, the difference
disappeared (data not shown).
To assess ROS formation, BF were preloaded with CM-
H2DCFDA, which becomes fluorescent upon oxidation. Dye-
loaded parasites were then treated for two or four hours with the
compounds at concentrations that would yield approximately a
75% or 90% reduction in the number of live cells by 24 hours. In
addition, due to the shorter exposure time, the parasites were also
tested at twice the 24 hour EC90 concentration. As a control, the
known oxidizing reagent hydrogen peroxide was applied for one
hour (Figure S3 shows the dose-response curve). At the EC50,
hydrogen peroxide yielded about 3-fold more ROS signal than
seen as background in untreated cells. Only two of the
compounds, camptothecin and quercetin, showed reproducible
fluorescence above background (Figure 2B), and changes were
much more modest. However, fluorescence was increased at four
versus two hours of treatment, indicating a cumulative effect. In
contrast, untreated BF showed decreased fluorescence at four
hours, suggesting slow loss of the dye. A previous study [15]
showed increased ROS following PGD2 treatment, which we did
not observe. However, those studies utilized stationary phase BF
rather than log phase BF as employed here.
The ATP concentration in aliquots of cells in culture medium
was measured after 24 hours of drug treatment as described in the
Materials and Methods. When the number of live cells was
decreased by approximately 75%, the ATP level also decreased
but only about half as much (Table 3). Thus measurement of ATP
levels at 24 hours is not as sensitive in revealing drug effects as
other methods such as scatter or live/dead staining combined with
particle counting. Others have measured ATP levels to assess
compound effects in screening assays; those assays used a longer
drug exposure period (48 hours) [2] which would magnify the
differences between treated and untreated samples. Interestingly,
at high parasite density (these cultures had passed out of log phase
growth and were at a density of 2.8610
6 cells/ml) the ATP
level dropped three-fold on a per cell basis, even though the
population was still highly viable as measured by forward and side
scatter.
Figure 1. Analysis of BF viability by flow cytometry. A) On the
left are untreated cells and on the right are cells treated with
pentamidine. The top panels show staining with ethidium (dead cells
are permeable to the dye) and calcein (live cells hydrolyze the
fluorogenic substrate). The bottom panels show the forward and side
scatter, with gates drawn to indicate the region containing live cells. B)
The pentamidine-treated cells were divided into two populations by
forward/side scatter as shown in Figure 1A and analyzed for calcein/
ethidium staining.
doi:10.1371/journal.pntd.0000678.g001
Table 2. Plating efficiency following drug treatment.
Compound
Relative
inhibition
a % dead cells
Plating
efficiency (%)
untreated 4.4 95
camptothecin 76.9 29.5 68
etoposide 65.5 23.6 23
THQ4G 69.6 20.8 8
quercetin 69.3 19.8 53
PGD2 69.9 25.7 28
pentamidine 25.5 10.9 0.4
pentamidine 75.8 51.9 ,0.02
b
aAverage decrease in number of live cells as compared to untreated cultures, in
multiple plating experiments.
bPlating 200 live cells per well (24 wells per experiment) gave rise to no
colonies. This number (0.02) assumes the next well would have given rise to a
colony.
doi:10.1371/journal.pntd.0000678.t002
Diverse Responses to Drugs in T. brucei
www.plosntds.org 5 May 2010 | Volume 4 | Issue 5 | e678Effects on cell cycle and organelle segregation
Some drugs affect cell cycle progression or result in degradation of
DNA, causing decreased population growth or cell death. Two drugs
studied here, the topoisomerase inhibitors etoposide and camptothe-
cin, are known to have such effects in other organisms. T. brucei has
both a nuclear DNA cycle and a mitochondrial DNA (kinetoplast or
kDNA) cycle. The division of the single kinetoplast precedes that of
the nucleus, such that parasites progress from a one nucleus and one
kinetoplast (1N1K) G1 cell to a 1N2K cell that is in late S-phase or
G2, to a 2N2K cell that has completed nuclear division. When the
nucleus or kinetoplast fail to replicate, divide, or position properly,
aberrant, dead-end progeny result, such as those with two nuclei and
one kinetoplast (2N1K) or no nucleus and one kinetoplast (0N1K,
also called zoids). Figure 3A shows the DNA content of drug-treated,
fixed parasites analyzed by flow cytometry, while Figure 3B shows its
cellular distribution visualized by fluorescence microscopy.
As seen in Figure 3A, the untreated populations show a very
large G1 peak, a smaller trough containing S phase cells, and a
moderately sized G2/M peak. A significant sub-G1 peak is not
seen in this healthy population. In contrast, each drug induced a
significant sub-G1 peak, which was especially prominent for
etoposide, pentamidine, and PGD2. This sub-G1 peak would be
expected to include dead cells with degraded nuclear DNA as well
as anucleate parasites containing only kDNA. Etoposide, and to a
lesser extent camptothecin, caused an increase in late S-phase/G2-
phase cells, which was expected since they are both topoisomerase
inhibitors. Etoposide, which specifically inhibits class II topoisom-
erases, did not cause a significant increase in abnormal genome
segregation patterns at the time point studied but did show a large
increase in 1N2K cells, consistent with the G2 arrest seen by flow
cytometry. This fits well with the known role of topoisomerase II in
untangling chromosomes during mitosis. Pentamidine treatment
caused a large increase in the proportion of parasites lacking
kDNA as has been previously observed [33], and an increase in
the number of cells with S-phase and possibly those with G2/M
DNA content. THQ4G also caused a very prominent increase in
the G2/M peak and an emergence of a.G2 peak (4N and
greater). Microscopic analysis showed that there was a marked
increase in parasites with two nuclei and one or two kinetoplasts,
correlating to the increased G2/M peak seen on flow cytometry.
In addition a number of parasites had more than two nuclei,
indicating a defect in cell division. Morphology was dramatically
affected by treatment with THQ4G, with many parasites showing
a refractile ‘‘big eye’’ appearance that was not seen with the other
drugs. The ‘‘big eye’’ phenotype was previously seen in parasites
defective in endocytosis; it represents swelling at the flagellar
pocket where endocytosis occurs [34]. Quercetin did not have a
Figure 2. Assays of mitochondrial potential and generation of
ROS in drug-treated parasites. A) Mitochondrial potential. After
24 hour drug treatment, parasites were incubated with rhodamine 123
and analyzed by flow cytometry. Dead cells, which were present in all
samples, were excluded by gating on scatter. The arrow marks the
midpoint for the untreated control. The legend includes the results
from multiple experiments, showing the percentage decrease in
number of live cells, average and standard deviation of rhodamine
123 fluorescence expressed as the ratio of the geometric means of the
treated samples versus the untreated sample. B) Generation of ROS.
Amount of ROS above that seen in untreated cells following a two-hour
exposure to the indicated drugs at two different concentrations (see
Table 1). ROS were assayed by flow cytometric detection of oxidized
CM-H2DCFDA.
doi:10.1371/journal.pntd.0000678.g002
Table 3. ATP levels in drug-treated cells.
Relative live cell
number Relative ATP nM ATP±S.D.
camptothecin 0.22 0.78 10.4061.42
etoposide 0.28 0.88 11.7060.63
THQ4G 0.33 0.78 10.4260.52
quercetin 0.19 0.41 5.4661.06
PGD2 0.57 0.80 10.5960.96
pentamidine 0.29 0.34 4.5760.40
untreated 1 1 13.862.40
Relative live cell number and ATP are in comparison to untreated cells.
doi:10.1371/journal.pntd.0000678.t003
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PGD2-treated cultures showed a loss of S-phase cells. Overgrown
cells showed an increase in G1.
Assays for PCD
Two of the drugs included in these studies, PGD2 and quercetin,
have been implicated as eliciting a possible PCD mechanism in T.
brucei. One hallmark of the apoptotic mode of PCD is the
depolarization of the plasma membrane, in which the normally
cytoplasmically facing phosphatidylserine is flipped to external
face of the intact membrane bilayer. Exposed phosphatidylserine
can be detected with annexin-V, a cell-impermeant protein. To
verify that the cells have not lost membrane integrity (which would
allow annexin-V binding to internal phosphatidylserine), the
Figure 3. DNA content and genome segregation following drug treatment. A) DNA content following 24 hour treatment revealed by PI
staining of RNAse treated BF. The large peak at left seen in some samples represents cells with degraded DNA. 2C indicates diploid (G1) DNA content,
4C indicates G2/M DNA content. Note the appearance of cells with sub-G1 DNA (peaks at far left) following some treatments, as well as cells with
higher order DNA content. In each case, the total number of live cells was less than 50% of the untreated controls. The percentage of dead cells (%{)
is indicated on each graph. B) Duplication and segregation of the nucleus and kinetoplast following drug treatment. The same populations of cells
analyzed in Figure 3A were subjected to microscopic analysis, enumerating the number of nuclei and kinetoplasts per cell as revealed by DAPI
staining. Forms seen during normal cell cycle progression are indicated by blue shades, while red to yellow shades indicate abnormal, dead end
forms. N, nucleus, K, kinetoplast.
doi:10.1371/journal.pntd.0000678.g003
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able stain PI. A parasite undergoing canonical apoptotic PCD
should stain positive for annexin-V, but negative for PI. Under the
conditions used, we never observed a clear annexin-positive/PI-
negative population. Untreated cultures showed few cells staining
with PI or annexin. The treated cultures all had similar patterns of
staining (Figure 4A shows results from four drugs). Populations
with moderate to high annexin staining emerged, and all showed
increased PI staining. When the samples were gated on scatter
(Figure 4B), all of the annexin-positive populations showed the low
forward scatter indicative of dead cells. The reasons for multiple
annexin-positive, PI-positive populations are unclear, but cells
with sub-G1 DNA content are clearly present (as seen in Figure 3)
and DNA degradation could reduce staining with PI.
A second hallmark of PCD is the activation of specific proteases,
most notably caspases. While the T. brucei genome does not encode
any homologues of classical caspases, it does encode many other
proteases including metacaspases. To determine if proteases with
caspase-like substrate specificity were activated upon drug
treatment, we used the cell permeant pancaspase substrate
FITC-VAD-fmk. Cleavage of the fluorogenic substrate leads to
increased fluorescence, detectable by flow cytometry. In the
related parasite Leishmania, it has been observed that treatment of
the parasites with nitric oxide, miltefosine, or hydrogen peroxide
(albeit at a lower level) can activate a protease that cleaves this
substrate (N. Fasel, personal communication). BF cultures treated
with hydrogen peroxide had a population of parasites that had
significantly increased protease activity directed towards this
substrate. However, BF cultures that were treated with the other
compounds at their EC50 or higher showed no intact cells that had
significantly increased fluorescence (data not shown). We did
observe that there was a slight increase in fluorescence in the dead
cells (those with low forward scatter) regardless of the treatment.
Depletion of potential drug targets via RNAi
We next used selected assays to examine the consequences of
genetic knockdown of genes known or suspected to be essential in
BF. The targets of three of the compounds tested above are
Figure 4. Annexin V staining of populations with dying cells. A) Annexin V and PI staining of unfixed cells. Untreated cells show
predominantly annexin V-negative, PI-negative staining (lower left quadrant). All drug treated cells showed additional populations with higher
annexin staining coupled with low to high PI staining. B) Annexin-positive cells are dead. The pentamidine-treated population shown in A was
analyzed according to light scattering properties. The low forward scatter, dead population (D) contained all annexin-stained cells, including those
with low to high PI staining. The live population contained the annexin-negative, PI-negative cells.
doi:10.1371/journal.pntd.0000678.g004
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are the targets of camptothecin, etoposide, and THQ4G
respectively. The parasite encodes multiple isoforms of topoisom-
erases. For the current studies we used RNAi to target
topoisomerase IB large and small subunits (TOPIBL and
TOP1BS, which gave similar results in all studies) and mitochon-
drial topoisomerase II (TOPIImt), both of which were previously
shown to be essential in procyclic forms [25,26,35]. We also
targeted the beta subunit of PFT.
Three other RNAi or conditional knockout lines were chosen
for analysis because they target disparate key functions of the cell.
PEX19 is involved in targeting of proteins to the glycosome, which
compartmentalizes the first steps of glycolysis and glycerol
metabolism [21,36]. Failure to properly localize glycosomal
proteins leads to the accumulation of toxic levels of intermediates
in these pathways [37] and cell death [38]. KREPA3 is a
component of the mitochondrial RNA editosome, which prepares
mitochondrial transcripts for translation by insertion or deletion of
uridines [19]. The nucleolar protein NOPP44/46 is involved in
biogenesis of the large ribosomal subunit [22]. For RNAi lines,
addition of Tet to the media induces knockdown of the
corresponding mRNA. For the conditional knockout of KREPA3,
removal of Tet blocks the expression of the complementing gene.
Although some of these genes had not previously been tested for
essentiality in BF (TOPIBL and TOP1BS, TOPIImt, and NOPP44/
46), all strains showed compromised growth after disruption of
gene expression (Figure 5 and Figure S4). From initial growth
curves, we determined when the growth of the strains was strongly
affected, which varied depending on the gene. Within the period
when population expansion was strongly impacted and before
resistant populations emerged, samples were analyzed with
selected assays.
In most cases, if knockdown dramatically reduced the numbers
of parasites, then it was also accompanied by cell death. A notable
exception was the knockdown of PFTb, which showed little cell
death even though cell numbers were decreased by over 60% by
day 3. The amount of cell death varied among the other RNAi cell
lines, as assessed by either forward/side scatter or calcein/
ethidium (the two methods agreed closely). The proportion of live
parasites by these two approaches also agreed closely with the
proportion of annexin-negative, PI-negative parasites. Similar to
what was seen following treatment with drugs, there was not clear
evidence for exposure of phosphatidylserine on intact parasites
(data not shown). The well-known propensity of T. brucei to
become resistant to the effects of specific RNAi would make
limiting dilution analysis difficult to interpret, so such studies were
not conducted.
Effect of RNAi on mitochondrial potential
As seen in Table 4, depletion of either subunit of TOPIB led to
a slight increase in mitochondrial membrane potential, which
corresponded to a small increase in cell size. This result is
consistent with what was seen for cells treated with camptothecin.
In contrast, cells depleted for either TOPIImt, and to a lesser
extent, PFTb, lost mitochondrial potential, a feature that was not
evident when cells were treated with drugs that inhibit these
enzymes. Down-regulation of the three other targets, KREPA3,
PEX19 and NOPP44/46, also resulted in at least a two-fold loss of
rhodamine 123 fluorescence.
Effect of target down-regulation on cell cycle and
genome segregation
Down-regulation of most of the targets led to a large increase in
the sub-G1 peak (Figure 6A), indicating DNA degradation or
production of anucleate parasites, as well as defects in organellar
replication or segregation (Figure 6B). Induction of RNAi for the
large subunit of TOPIBL (and TOP1BS, data not shown) yielded
the most aberrant profiles. These populations had the largest sub-
G1 peak, plus a dramatic increase in the number of parasites
Figure 5. Representative growth curves for RNAi cell lines
targeting TOPIBL, NOPP44/46, or TOPIImt. Tet was added at day 0
to initiate destruction of the targeted RNA. The RNAi-induced cells from
the final day of the growth curve were used in the experiments shown
in Figure 6. The percent of dead cells at that point is listed. NOPP44/46
protein levels were reduced 44% as shown by immunoblotting
(unpublished results).
doi:10.1371/journal.pntd.0000678.g005
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proportion of cells with 4C (G2/M) or 8C DNA content in the
absence a corresponding increase in the number of nuclei,
indicating a mitotic defect. The NOPP44/46 knockdown also
showed an enrichment of G2/M phase cells coupled with fewer
G1 and S phase cells. In contrast, decreased KREPA3 or
TOPIImt resulted in a fewer cells in G2/M phase. These mutants
also showed a massive increase in cells lacking a kinetoplast
(0N1K). PFT-b RNAi resulted in decreased S phase combined
with an increase in 1N2K and 2N2K cells. However, there was no
major increase in aberrant segregation events, except for a higher
level of multinucleate cells. PEX19 RNAi lines did not show any
major changes in the cell cycle.
Discussion
In this report we examined the effect of six drugs and six genetic
knockdowns on multiple cellular parameters in an effort to define
characteristics accompanying death of T. brucei BF, particularly
those that might be amenable to assessment in medium- to high-
throughput screens. All of the drugs were apparently static at lower
concentrations, but killed at higher concentrations. ATP levels
were a less sensitive measure of the numbers of live parasites than
the combination of particle counting and flow analysis. Several
explanations could be posed for the lag in ATP reduction as
measured, such as enlarged cell size (as with etoposide and
camptothecin), release of ATP by dying cells, decreased consump-
tion of ATP (due to cessation of energy intensive processes) or,
perhaps less likely, increased production of ATP. We found that
flow assays detecting decreased forward scatter, increased
ethidium or PI staining, and increased annexin V staining all
identified dead BF effectively. Coupling forward and side scatter or
ethidium with calcein staining provides a clear two dimensional
separation of the live and dead populations by flow cytometry.
Importantly, when tested at similar ECs, the plating efficiencies of
apparently live parasites varied widely depending on the
compound used, indicating that the relative number of live cells
does not necessarily predict the long term effects of a brief drug
treatment. Similarly, none of the other assays (ATP levels, ROS,
cell cycle, or genome segregation) were able to clearly predict
which of the compounds in this survey would have strong
irreversible effects. Thus, clonal proliferation assays may be a
useful step in down-selection of compounds identified by high-
throughput screening.
The diverse cellular effects following the different treatments are
summarized in Table 5. The six drugs fell into two broad groups;
those that affected mitochondrial membrane potential, and those
that decreased the G1/G2 ratio. The three drugs of unknown
mode of action (PGD2, quercetin, and pentamidine) behaved
similarly. These drugs caused a loss of mitochondrial membrane
potential and marked DNA degradation, but had relatively little
effect on the G1/G2 ratio or cellular morphology prior to death.
In comparison, the drugs THQ4G, etoposide, and camptothecin
all affected cell morphology and lead to an increase in the relative
numbers of G2 cells. For example, etoposide and camptothecin
both created larger cells and G2 arrest, with etoposide doing so to
a greater extent. THQ4G produced the largest effect on
morphology, with large round ‘‘BigEye’’ cells, huge G2 peaks
and a prominent .2N peak detected by flow cytometry. One
compound from each group caused modestly increased ROS:
quercetin and camptothecin. One compound from each group led
to highly decreased viability: pentamidine and THQ4G. Thus a
variety of phenotypes were apparent when the parasites were
treated with the toxic compounds even though the decrease in the
numbers of live cells was similar at 24 hours.
Theresultswith topoisomerasesand farnesyltransferase highlight
some challenges in predicting drug inhibition phenotypes from
RNAi and vice versa. The only drug-RNAi comparison which is
predicted to be unambiguous is THQ4G and PFT-b. However, the
PFT-b RNAi line did not show the dramatic morphological effect
that THQ4G did, and despite strongly decreased growth, the
knockdown did not evoke a large amount of cell death. Many
explanations can be proposed for this finding, such as sufficient
residual PFT-b afterRNAi toallow viability(similareffectsmight be
seen at low drug concentrations). Additionally, rapid inhibition via
drugs may not allow compensatory changes that could occur during
slower loss of activity as in RNAi knockdowns. Alternatively, the
stronger effect of the drug could result from off-target effects or the
cellularconsequencesofaninactive,drug-boundproteinasopposed
to the absence of the protein.
Although the effectiveness of TOPIImt RNAi was clearly
evident in the strongly reduced mitochondrial membrane potential
and production of anucleate cells, it had a less pronounced effect
on BF proliferation than did the topoisomerase II inhibitor
etoposide. This suggests that the primary target of etoposide in BFs
is not TOPIImt, but rather the nuclear topoisomerase IIa, which
was previously shown to be essential in procyclic forms [29].
Conversely, induction of RNAi against TOPIB large or small
subunits led to more dramatic cell cycle perturbations than did
camptothecin. This was unanticipated since, in addition to
topoisomerase IB [25], camptothecin is expected to act on all
three type IA/III enzymes, including an essential mitochondrial
isoform [39]. Indeed camptothecin form adducts with both kDNA
and nuclear DNA in BF [28], indicating action against nuclear
and mitochondrial isoforms.
Our study, which examines some of the commonly used assays,
shows that different treatments elicited somewhat different
response profiles in BF. The large number of differences between
Table 4. Effect of depletion of target molecules on parasite
growth, viability, mitochondrial potential.
Gene
Relative live
cell number
a % dead cells Relative mito y
b
TOPIBS n.d. 35 1.10
0.16 28 1.34
TOPIBL n.d. 72 1.33
0.21 28 0.93
TOPIImt 0.08 44 0.44
0.51 19 0.33
PFTB 0.36 14 0.72
0.3 17 0.68
PEX19 n.d. 64 0.47
0.26 61 0.52
KREPA3 0.05 37 0.19
0.15 19 0.41
NOPP44/46 0.04 26 0.34
0.12 17 0.53
aDefined as the cumulative reduction in live cell number relative to uninduced
controls at day of assay. TOP1BS, TOP1BL,a n dPEX19 knockdowns were assayed
on day 2 post induction of RNAi, while PFTB and NOPP44/46 knockdowns were
assayed on day 3 and TOPIImt on day 6. KREPA3 was assayed five days after
removal of Tet.
bas compared to control cells in the same experiment.
doi:10.1371/journal.pntd.0000678.t004
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well as host environment, could mean that mechanisms of parasite
death vary between the two stages in this species as well. Still it is
possible that cellular events precipitated by drugs or genetic
intrusions ultimately rely on limited number of pathways to cause
cell death. Clearly, there are many other parameters that could be
examined in efforts to elucidate such pathways in the future.
Whether these responses result from the induction of genetic
programs as opposed to biochemical cascades remains to be
studied.
Figure. 6. DNA content and genome segregation following genetic knockdown. The same parasites described in Table 4 were analyzed for
DNA content (Panel A) and nuclear and kinetoplast genome segregation (Panel B) as described in Figure 3. The cumulative number of live cells was
between 10% and 50% of control uninduced populations on the day assayed.
doi:10.1371/journal.pntd.0000678.g006
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dylserine on the outer leaflet of the plasma membrane, is considered
to be a hallmark of apoptotic cell death. The externalization of
phosphatidylserine is thought to involve activation of lipid
scramblases[40] (apparentlylackinginT.brucei)and/orinactivation
of aminophospholipid translocases [41] (several of which appear to
be present in T. brucei). Our studies did not reveal any evidence for
exposure of phosphatidylserine except when the plasma membrane
was compromised. These conditions included treatment with PGD2
and quercetin, both of which have been implicated in a possible
PCD pathway in T. brucei BF. Although work by previous authors
showed evidence of phosphatidylserine exposure upon treatment
with these drugs, those studies used stationary phase BF whereas we
employed log phase parasites. Because stationary phase BF go on to
die relatively rapidly even in the absence of drugs, their death
pathways might be somewhat different to what is seen in log phase.
More recently, evidence has been presented for phosphatidylserine
exposure in the absence of significant membrane permeabilization
in BF treated with cordycepin [42] or subjected to endoplasmic
reticulum stress [43]. This finding suggests that under certain
situations loss of membrane asymmetry may occur as BF die. None
of the compounds we studied evoked protease activity against the
pan-caspase substrate FITC-VAD-fmk. While we were unable to
find evidence for a classical apoptotic pathway, some drugs did elicit
a set of apparently live cells that were unable to further proliferate,
suggesting that a genetic or biochemical program had been initiated
during the initial insult. Whether such programs directly parallel
those seen in metazoa is open to question.
All of the compounds we employed killed cells under acute
treatment, but only pentamidine is used for treatment of human
African trypanosomiasis. Following exposure to this drug, and to a
lesser extent THQ4G, cells that retained all of the markers of
viability had nevertheless started down a one-way journey to their
demise. Further knowledge of how to precipitate the events
initiated by these compounds would provide important clues for
designing new anti-trypanosomal drugs. The strategy of antigenic
variation employed by the parasites means that little help is
available from adaptive immunity, raising the bar even higher for
drug efficacy.
Supporting Information
Figure S1 Titration curves for drugs. The effects of drugs were
monitored by flow cytometry to detect live and dead cells.
Found at: doi:10.1371/journal.pntd.0000678.s001 (0.02 MB PDF)
Figure S2 The proportion of live cells compared to inhibition of
population expansion. The effects of different concentrations of
drugs on the total number of live parasites and the proportion of
live versus dead cells in the population.
Found at: doi:10.1371/journal.pntd.0000678.s002 (0.03 MB PDF)
Figure S3 Titration of hydrogen peroxide in the ROS assay.
The effect of hydrogen peroxide in ROS and live/dead assay is
shown.
Found at: doi:10.1371/journal.pntd.0000678.s003 (0.06 MB PDF)
Figure S4 Growth curves for genetic knockdowns. Growth
curves for cell lines not depicted in Fig. 5. The cells from the final
day of the growth curve were used in the experiments shown in
Figure 6.
Found at: doi:10.1371/journal.pntd.0000678.s004 (0.04 MB PDF)
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Table 5. Summary of differential effects of drugs and RNAi on T. brucei BF.
a
Drug/RNAi target Plating efficiency Mito potential ROS Cell cycle Nucleus+kDNA
campothecin Top I 22++ +
etoposide Top II + 22 +++ +
THQ4G PFT +++ 22 +++ +++
pentamidine ? +++ +++ 2 +++ +++
PGD2 ? + +++ 2 +++ +
quercetin ? 2 ++ 2 +
Reg. knockout KREPA3 nd +++ 2 +++ +++
RNAi TOPIImt nd +++ 2 +++ +++
RNAi TOPIB nd 2 nd +++ +++
RNAi PFT-b nd + nd ++
RNAi NOPP44/46 nd +++ 2 +++ nd
RNAi PEX19 nd +++ 22 +
a–, no effect; + limited effect; +++, significant effect following RNAi or 24 hour treatment with drugs at IC75 concentration were defined as noted below. Not done, nd.
- plating efficiency: percentage of cells categorized as live by scatter able to form colonies, compared to untreated. Limited effect, 2–5 fold reduction; significant effect,
.5-fold reduction.
- mitochondrial potential: limited effect, 30250% reduction; significant effect, .50% reduction.
- ROS: limited effect, 5230% increase in CM-H2DCFDA staining; significant effect, greater than 30% increase.
- cell cycle profile among cells with G1 content or greater: limited effect, G1/G2 or S/G1+G2 1.522 standard deviations from untreated cells; significant effect, .2
standard deviations from untreated cells.
- Nucleus+kDNA: limited effect, 10230% cells having abnormal numbers of nuclei or kinetoplasts, significant effect .30% abnormal forms.
doi:10.1371/journal.pntd.0000678.t005
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